[Research progress on calcification mechanism and anti-calcification strategies of vascular grafts]

Xiaomeng Su1, Fanshan Qiu1, Han Wang1

  • 1National Institutes for Food and Drug Control, Beijing 102629, P. R. China.

Insights

Artificial blood vessels are crucial for cardiovascular disease treatment. This review explores calcification mechanisms and anti-calcification strategies to improve artificial vessel function and prevent graft failure, especially in small-diameter grafts.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Surgery
  • Medical Engineering

Background:

  • Artificial blood vessels are vital for treating cardiovascular diseases.
  • Graft calcification is a major cause of artificial vessel failure, particularly in small-diameter grafts.
  • Understanding calcification mechanisms is key to improving graft longevity.

Purpose of the Study:

  • To summarize the calcification mechanisms in artificial blood vessels.
  • To review current anti-calcification strategies for artificial grafts.
  • To provide insights for developing improved anti-calcification artificial vessels.

Main Methods:

  • Literature review of calcification mechanisms in artificial vessels.
  • Analysis of factors contributing to graft calcification.
  • Compilation of existing and emerging anti-calcification strategies.

Main Results:

  • Calcification significantly impacts the patency and success of artificial blood vessel transplants.
  • Small-diameter grafts are more susceptible to calcification-induced failure.
  • Various strategies exist to prevent or delay post-implantation calcification.

Conclusions:

  • Further research into calcification mechanisms is essential.
  • Development of effective anti-calcification strategies is critical for long-term graft patency.
  • This review provides a foundation for future innovations in artificial vessel technology.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...